Bank Pictet & Cie Europe AG lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 245,730 shares of the healthcare conglomerate’s stock after purchasing an additional 3,370 shares during the quarter. UnitedHealth Group comprises 1.7% of Bank Pictet & Cie Europe AG’s investment portfolio, making the stock its 12th biggest holding. Bank Pictet & Cie Europe AG’s holdings in UnitedHealth Group were worth $84,851,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Bayforest Capital Ltd lifted its stake in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. LFA Lugano Financial Advisors SA bought a new position in UnitedHealth Group during the second quarter valued at $25,000. Sagard Holdings Management Inc. bought a new position in UnitedHealth Group during the second quarter worth about $29,000. Islay Capital Management LLC bought a new position in UnitedHealth Group in the 2nd quarter worth approximately $31,000. Finally, Nova Wealth Management Inc. raised its stake in shares of UnitedHealth Group by 339.1% during the 1st quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock valued at $53,000 after purchasing an additional 78 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts have weighed in on the company. Leerink Partners set a $410.00 price target on UnitedHealth Group and gave the company an “outperform” rating in a report on Wednesday, October 29th. JPMorgan Chase & Co. upped their target price on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Piper Sandler dropped their price objective on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a report on Tuesday, October 28th. Finally, Royal Bank Of Canada lifted their target price on shares of UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Seventeen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Hold” and an average target price of $385.54.
UnitedHealth Group Stock Performance
UNH stock opened at $330.32 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.82. The company has a market cap of $299.22 billion, a P/E ratio of 17.24, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The stock’s fifty day moving average price is $331.11 and its 200-day moving average price is $319.52.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. During the same period in the previous year, the company posted $7.15 EPS. The firm’s revenue was up 12.2% on a year-over-year basis. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend was Monday, December 8th. UnitedHealth Group’s dividend payout ratio is 46.14%.
UnitedHealth Group Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Read More
- Five stocks we like better than UnitedHealth Group
- GOLD ALERT
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- The $100 Trillion AI Story No One Is Telling You
- Bombshell Exposé on China Strikes
- Do not delete, read immediately
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
